MHC class I molecules and kirs in human history, health and survival

Parham, Peter·2005·Nature Reviews Immunology

Cited by (1,000)

Items 101–200 of 1,000

  1. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases
    Lluís Quintana‐Murci, Alexandre Alcaïs, Laurent Abel, Jean‐Laurent Casanova · 2007 · Nature Immunology
  2. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors
    Wei Jiang, Chris Johnson, Jyothi Jayaraman, Nikol Simecek, Janelle Annette Noble, Miriam F. Moffatt, William Cookson, John Trowsdale, James A. Traherne · 2012 · Genome Research
  3. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
    Fosby, Bjarte · 2012 · World Journal of Gastroenterology
  4. A syntaxin 10–SNARE complex distinguishes two distinct transport routes from endosomes to the trans-Golgi in human cells
    Ian G. Ganley, Eric J. Espinosa, Suzanne R. Pfeffer · 2008 · The Journal of Cell Biology
  5. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
    Loredana Ruggeri, Franco Aversa, Massimo F. Martelli, Andrea Velardi · 2006 · Immunological Reviews
  6. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
    Rajagopalan, Sumati, Long, Eric O. · 2012 · Proceedings of the National Academy of Sciences
  7. NK-/T-cell lymphomas
    Hua Wang, Bibo Fu, Robert Peter Gale, Yang Liang · 2021 · Leukemia
  8. Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles
    James Robinson, Lisbeth A. Guethlein, Nezih Cereb, Soo Young Yang, Paul J. Norman, Steven G. E. Marsh, Peter Parham · 2017 · PLoS Genetics
  9. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease
    Rosemary Jane Boyton, Daniel Martin Altmann · 2007 · Clinical & Experimental Immunology
  10. Altered Natural Killer Cells in Type 1 Diabetic Patients
    Melanie Rodacki, Britta M. Svoren, Vincent L. Butty, Whitney Besse, Lori M. Laffel, Christophe O. Benoist, Diane J. Mathis · 2006 · Diabetes
  11. Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions
    Ilwoong Hwang, Tianxiang Zhang, Jeannine M. Scott, Ae Ra Kim, Taehyung Lee, Tejaswi Kakarla, Ahrom Kim, John B. Sunwoo, Sungjin Kim · 2012 · International Immunology
  12. Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
    Kelly L. Hudspeth, Bruno Silva‐Santos, Domenico Mavilio · 2013 · Frontiers in Immunology
  13. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions
    Elena Tomasello, Éric Vivier · 2005 · European Journal of Immunology
  14. Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)
    Amanda K. Purdy, Kerry S. Campbell · 2009 · Cancer Biology & Therapy
  15. Exploitation of natural killer cells for the treatment of acute leukemia
    Rupert Handgretinger, Peter Lang, Maya Caroline Andre · 2016 · Blood
  16. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
    Loredana Ruggeri, Antonella Mancusi, Emanuela Burchielli, Marusca Capanni, Alessandra Carotti, Teresa Aloisi, Franco Aversa, Massimo F. Martelli, Andrea Velardi · 2007 · Blood Cells Molecules and Diseases
  17. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
    Golo Ahlenstiel, Maureen P. Martin, Xiaojiang Gao, Mary N Carrington, Barbara Rehermann · 2008 · Journal of Clinical Investigation
  18. Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight
    Susan E. Hiby, Richard Apps, Olympe Chazara, Lydia E. Farrell, Per Minor Magnus, Lill Trogstad, Håkon Kristian Gjessing, Mary N Carrington, Ashley Moffett · 2014 · The Journal of Immunology
  19. Human Gut-Associated Natural Killer Cells in Health and Disease
    Alessandro Delli Poggi, Roberto Benelli, Roberta Venè, Delfina Costa, Nicoletta Ferrari, Francesca Tosetti, Maria Raffaella Zocchi · 2019 · Frontiers in Immunology
  20. Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age
    Andrew Sharkey, Lucy Gardner, Susan E. Hiby, Lydia E. Farrell, Richard Apps, Leanne M. Masters, Jodie P. Goodridge, Louise J. Lathbury, C Andrew Stewart, Sanjay Verma et al. · 2008 · The Journal of Immunology
  21. Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig–like Receptor in Patients Transplanted with NKG2C−/− Umbilical Cord Blood
    Mariella Della Chiesa, Michela Falco, Alice Bertaina, Letizia Muccio, Claudia Alicata, Francesco Frassoni, Franco Locatelli, Lorenzo Moretta, Alessandro Moretta · 2014 · The Journal of Immunology
  22. How Does the Maternal Immune System Contribute to the Development of Pre-eclampsia?
    Ashley Moffett, S.E. Hiby · 2007 · Placenta
  23. Putting the natural killer cell in its place
    Geraldine M. O’Connor, Orla M. Hart, Clair M. Gardiner · 2005 · Immunology
  24. Major histocompatibility complex genotyping with massively parallel pyrosequencing
    Roger W. Wiseman, Julie A. Karl, Benjamin N. Bimber, Claire E. O’Leary, Simon M. Lank, Jennifer J. Tuscher, Ann M. Detmer, Pascal Bouffard, Natalya Levenkova, Cynthia L. Turcotte et al. · 2009 · Nature Medicine
  25. HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors
    Jodie P. Goodridge, Aura Burian, Ni Lee, Daniel E. Geraghty · 2013 · The Journal of Immunology
  26. Markers and function of human NK cells in normal and pathological conditions
    Genny Del Zotto, Emanuela Marcenaro, Paola Vacca, Simona Sivori, Daniela Pende, Mariella Della Chiesa, Francesca Moretta, Tiziano Ingegnere, Maria Cristina Mingari, Alessandro Moretta et al. · 2017 · Cytometry Part B Clinical Cytometry
  27. An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation
    Nicolas Dulphy, Philippe Haas, Marc Busson, Stéphanie Belhadj, Régis Peffault de Latour, Marie Robin, Maryvonnick Carmagnat, Pascale Loiseau, Ryad Tamouza, Catherine Scieux et al. · 2008 · The Journal of Immunology
  28. Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
    Jieming Zeng, Shin Yi Tang, Lai Ling Toh, Shu Wang · 2017 · Stem Cell Reports
  29. The extended human leukocyte receptor complex: diverse ways of modulating immune responses
    Alexander D. Barrow, John Trowsdale · 2008 · Immunological Reviews
  30. NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia
    Franco Locatelli, Daniela Pende, Michela Falco, Mariella Della Chiesa, Alessandro Moretta, Lorenzo Moretta · 2018 · Trends in Immunology
  31. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals
    Feng Wang, Hongyan Hou, Shiji Wu, Qing Tang, Weiyong Liu, Min Huang, Botao Yin, Jing Huang, Lie Mao, Yanfang Lu et al. · 2015 · European Journal of Immunology
  32. Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
    Lorenzo Moretta, Elisa Montaldo, Paola Vacca, Genny Del Zotto, Francesca Moretta, Pietro Merli, Franco Locatelli, Maria Cristina Mingari · 2014 · International Archives of Allergy and Immunology
  33. The unexpected effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopulations
    Hongbo Wang, Bartosz J. Grzywacz, David J. Sukovich, Valarie McCullar, Qing Cao, Alisa B. Lee‐Sherick, Bruce R. Blazar, David N. Cornfield, Jeffrey S. Miller, Michael R. Verneris · 2007 · Blood
  34. The evolution of immune mechanisms
    Nadia Danilova · 2006 · Journal of Experimental Zoology Part B Molecular and Developmental Evolution
  35. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation
    Jeanette E. Boudreau, Fabio Giglio, Ted Alan Gooley, Philip A. Stevenson, Jean-Benoît Le Luduec, Brian C. Shaffer, Raja Rajalingam, Lihua Hou, Carolyn Katovich Hurley, Harriet J. Noreen et al. · 2017 · Journal of Clinical Oncology
  36. NK and NKT cells in liver injury and fibrosis
    George Notas, Tatiana Kisseleva, David A. Brenner · 2008 · Clinical Immunology
  37. Pathogenesis of primary sclerosing cholangitis
    Marion Julia Pollheimer, Emina Halilbasic, Peter Fickert, Michael Trauner · 2011 · Best Practice & Research Clinical Gastroenterology
  38. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience
    Silvia Marina Vidal, Salim I. Khakoo, Christine A. Biron · 2011 · Current Opinion in Virology
  39. Donor–Recipient Combinations of Group A and B KIR Haplotypes and HLA class I Ligand Affect the Outcome of HLA-Matched, Sibling Donor Hematopoietic Cell Transplantation
    Karina L. McQueen, Kristel M. Dorighi, Lisbeth A. Guethlein, Ruby M. Wong, Bharati M. Sanjanwala, Peter Parham · 2007 · Human Immunology
  40. Regulatory NK-Cell Functions in Inflammation and Autoimmunity
    Anna Lünemann, Jan D. Lünemann, Christian Münz · 2009 · Molecular Medicine
  41. The major histocompatibility complex: a model for understanding graft-versus-host disease
    Effie Wang Petersdorf · 2013 · Blood
  42. HIV-1 Vpu Mediates HLA-C Downregulation
    Richard Apps, Gregory Q. Del Prete, Pramita Chatterjee, Abigail Lara, Zabrina L. Brumme, Mark A. Brockman, Stuart J. D. Neil, Suzanne Pickering, Douglas K. Schneider, Alicja K. Trocha et al. · 2016 · Cell Host & Microbe
  43. Chimpanzees in Biomedical and Behavioral Research
    Institute of Medicine and National Research Council · 2011 · National Academies Press eBooks
  44. Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection
    Megan M. Dring, Maria H. Morrison, Brian Patrick McSharry, Kieran J. Guinan, Richard Hagan, Cliona O’Farrelly, Clair M. Gardiner, Gary Courtney, Orla M. Crosbie, John Crowe et al. · 2011 · Proceedings of the National Academy of Sciences
  45. Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
    Alessandra Zingoni, Cinzia Fionda, Cristiana Borrelli, Marco Cippitelli, Angela Santoni, Alessandra Soriani · 2017 · Frontiers in Immunology
  46. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis
    Lorenzo Moretta, Cristina Bottino, Daniela Pende, Massimo Vitale, Maria Cristina Mingari, Alessandro Moretta · 2005 · Immunology Letters
  47. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
    Dirk H. J. Verhoeven, Alfons S.K. de Hooge, Esther Mooiman, Susy Justo Santos, Monique M. ten Dam, Hans A. J. Gelderblom, Cornelis J.M. Melief, Pancras C.W. Hogendoorn, Rudolph Maarten Egeler, Maarten J. D. van Tol et al. · 2008 · Molecular Immunology
  48. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells
    Yong Zhong, Kaopeng Guan, Sujuan Guo, Chunxia Zhou, Dongmei Wang, Wenbo Ma, Youhui Zhang, Changling Li, Shuren Zhang · 2010 · Cancer Letters
  49. Features of Memory-Like and PD-1+ Human NK Cell Subsets
    Mariella Della Chiesa, Silvia Pesce, Letizia Muccio, Simona Carlomagno, Simona Sivori, Alessandro Moretta, Emanuela Marcenaro · 2016 · Frontiers in Immunology
  50. Natural killer cell education in human health and disease
    Jeanette E. Boudreau, Katharine C. Hsu · 2018 · Current Opinion in Immunology
  51. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders
    C Chen, Marc Busson, Vanderson Rocha, M-L Appert, V. Lepage, Nicolas Dulphy, Philippe Haas, Gèrard Socié, Antoine Toubert, Dominique J Charron et al. · 2006 · Bone Marrow Transplantation
  52. Use of NK cell activity in cure by transplant
    Wing Hang Leung · 2011 · British Journal of Haematology
  53. Natural killer cells in HIV-1 infection and therapy
    Joanna Mikulak, Ferdinando Oriolo, Elisa Zaghi, Clara Di Vito, Domenico Mavilio · 2017 · AIDS
  54. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells
    Niklas K. Björkström, Vivien Béziat, Frank M. Cichocki, Lisa L. Liu, Jeffrey J. Levine, Stella Larsson, Richard A. Koup, Stephen K. Anderson, Hans‐Gustaf Ljunggren, Karl‐Johan Malmberg · 2012 · Blood
  55. Long contiguous stretches of homozygosity in the human genome
    Ling-Hui Li, Sheng-Feng Ho, Chien-Hsiun Chen, Chun-Yu Wei, Wan-Ching Wong, Li-Ying Li, Wen‐Hung Chung, Wen‐Hung Chung, Wen-Han Pan, Ming Ta Michael Lee et al. · 2006 · Human Mutation
  56. Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk
    Mary Peterson, Eric O. Long · 2008 · Immunity
  57. Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor
    Yasuo Morishima, Toshio Yabe, Keitaro Matsuo, Koichi Kashiwase, Hidetoshi Inoko, Hiroh Saji, Ken Yamamoto, Etsuko Maruya, Yoshiki Akatsuka, Makoto Onizuka et al. · 2007 · Transplantation and Cellular Therapy
  58. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes
    Paul J. Norman, Laurent Abi‐Rached, Ketevan Gendzekhadze, John A. Hammond, Achim K. Moesta, Deepti Sharma, Thorsten T. Graef, Karina L. McQueen, Lisbeth A. Guethlein, Christine V. F. Carrington et al. · 2009 · Genome Research
  59. Structural and regulatory diversity shape HLA-C protein expression levels
    Gurman Kaur, Stéphanie Gras, Jesse I. Mobbs, Julian P. Vivian, Adrián Cortés, Thomas R. Barber, Subita Balaram Kuttikkatte, Lise Torp Jensen, Kathrine E. Attfield, Calliope Athena Dendrou et al. · 2017 · Nature Communications
  60. Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality
    Antonella Mancusi, Loredana Ruggeri, Elena Urbani, Antonio Pierini, Maria Speranza Massei, Alessandra Carotti, Adelmo Terenzi, Franca Falzetti, Antonellá Tosti, Fabiana Topini et al. · 2015 · Blood
  61. Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies
    Camille Guillerey, Kyohei Nakamura, Slavica Vučković, Geoffrey R. Hill, Mark John Smyth · 2016 · Cellular and Molecular Life Sciences
  62. Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
    Laura Chiossone, Margaux Vienne, Yann M. Kerdiles, Éric Vivier · 2017 · Seminars in Immunology
  63. Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemias
    Alessandro Moretta, Franco Locatelli, Lorenzo Moretta · 2008 · Immunological Reviews
  64. Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art
    Vomstein, Kilian, Feil, Katharina, Strobel, Laura, Aulitzky, Anna, Hofer-Tollinger, Susanne, Kuon, Ruben-Jeremias, Toth, Bettina · 2021 · Journal of Clinical Medicine
  65. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands
    Ketevan Gendzekhadze, Paul J. Norman, Laurent Abi‐Rached, Thorsten T. Graef, Achim K. Moesta, Zulay E. Layrisse, Peter Parham · 2009 · Proceedings of the National Academy of Sciences
  66. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection
    Miguel López‐Botet, Aura Muntasell, Carlos Vilches · 2014 · Seminars in Immunology
  67. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT
    Simona Sivori, Simona Carlomagno, Michela Falco, Elisa Romeo, Lorenzo Moretta, Alessandro Moretta · 2011 · Blood
  68. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
    Achim K. Moesta, Peter Parham · 2012 · Frontiers in Immunology
  69. NK Cells: Immune Cross-Talk and Therapeutic Implications
    Anshu Malhotra, Anil Shanker · 2011 · Immunotherapy
  70. Natural Killer Cells: Tumor Surveillance and Signaling
    Lizeth G. Meza Guzman, Narelle Keating, Sandra E. Nicholson · 2020 · Cancers
  71. Quality Control in Self/Nonself Discrimination
    Thomas L. J. Boehm · 2006 · Cell
  72. A lesson for cancer research: placental microarray gene analysis in preeclampsia
    Frank Louwen, Cornelia Muschol-Steinmetz, Joscha Reinhard, Anke Reitter, Juping Yuan · 2012 · Oncotarget
  73. Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
    Cristina Bottino, Alessandra Dondero, Francesca Bellora, Lorenzo Moretta, Franco Locatelli, Vito Pistoia, Alessandro Moretta, Roberta Castriconi · 2014 · Frontiers in Immunology
  74. Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
    Yin Liu, Hong-Wei Wu, Michael Allen Sheard, Richard Sposto, Srinivas S. Somanchi, Laurence J.N. Cooper, Dean Anthony Lee, Robert C. Seeger · 2013 · Clinical Cancer Research
  75. Pathogenesis of psoriatic arthritis
    Allen Anandarajah, Christopher T. Ritchlin · 2004 · Current Opinion in Rheumatology
  76. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex
    James A. Traherne, Maureen P. Martin, R. D. Ward, Maki Ohashi, Fawnda Pellett, Dafna D. Gladman, Derek Middleton, Mary N Carrington, John Trowsdale · 2009 · Human Molecular Genetics
  77. A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells
    Mathias D. Lichterfeld, Daniel G. Kavanagh, Katie L. Williams, Beenu Moza Jalali, Stanley K. Mui, Toshiyuki Miura, Rohini Sivamurthy, Rachel L. Allgaier, Florencia Pereyra, Alicja Piechocka‐Trocha et al. · 2007 · The Journal of Experimental Medicine
  78. NK receptor interactions with MHC class I molecules in pregnancy
    John Trowsdale, Ashley Moffett · 2008 · Seminars in Immunology
  79. Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression
    Hongchuan Li, Véronique Pascal, Maureen P. Martin, Mary N Carrington, Stephen K. Anderson · 2008 · PLoS Genetics
  80. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation
    Bronwen E. Shaw, Rafael Arguello, Christian Alberto García-Sepúlveda, J. Alejandro Madrigal · 2010 · British Journal of Haematology
  81. Taking license with natural killer cell maturation and repertoire development
    Peter Parham · 2006 · Immunological Reviews
  82. HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction
    Sumati Rajagopalan · 2014 · Cellular and Molecular Immunology
  83. Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages
    Rehan Mujeeb Faridi, S. Agrawal · 2010 · Human Reproduction
  84. HLA and Other Gene Associations with Dengue Disease Severity
    Henry A. F. Stephens · 2009 · Current topics in microbiology and immunology
  85. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
    Ying‐Jun Chang, Leo Luznik, Ephraim Joseph Fuchs, Xiao‐Jun Huang · 2016 · Journal of Hematology & Oncology
  86. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients
    Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, Ana García-Soidán, Ana de Malet Pintos‐Fonseca, Nieves Alonso-Alarcón, Roberto Pariente, Amalia Tejeda Velarde, Sergio Serrano Villar, José Luis Castañer-Alabau, Israel Nieto-Gañán · 2020 · Clinical Immunology
  87. KIR haplotype content at the allele level in 77 Northern Irish families
    Derek Middleton, Ashley Meenagh, Pierre‐Antoine Gourraud · 2007 · Immunogenetics
  88. The genetic and evolutionary balances in human NK cell receptor diversity
    Peter Parham · 2008 · Seminars in Immunology
  89. KIR/HLA Interactions and Pathogen Immunity
    Khaleel M. Jamil, Salim I. Khakoo · 2011 · BioMed Research International
  90. Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
    Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, Linda Quatrini, Enrico Munari, Paola Vacca, Nicola Tumino, Francesca Romana Mariotti, Maria Cristina Mingari, Daniela Pende et al. · 2020 · Frontiers in Immunology
  91. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide
    Rodrigo Barquera, Evelyn Collen, Da Di, Stéphane Bühler, João C. Teixeira, Bastien Llamas, José Manuel Nunes, Alicia Sanchez‐Mazas · 2020 · HLA
  92. HLA-B*51 and Behçet Disease
    Ahmet Gül, Shigeaki Ohno · 2011 · Ocular Immunology and Inflammation
  93. NK Cells and Cancer Immunoediting
    Camille Guillerey, Mark John Smyth · 2015 · Current topics in microbiology and immunology
  94. Immune Checkpoint Blockade
    Jarushka Naidoo, David B. Page, Jedd D. Wolchok · 2014 · Hematology/Oncology Clinics of North America
  95. Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
    Robert Godal, Veronika Bachanová, Michelle Gleason, Valarie McCullar, Gong H. Yun, Sarah Cooley, Michael R. Verneris, Philip B. McGlave, Jeffrey S. Miller · 2010 · Transplantation and Cellular Therapy
  96. HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity
    Zakia Djaoud, Peter Parham · 2020 · Annual Review of Biochemistry
  97. Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11
    Jingxian Liu, Ziwei Xiao, Hui Ling Ko, Meixin Shen, Ee Chee Ren · 2014 · Proceedings of the National Academy of Sciences
  98. Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions
    Haifeng Song, Nicole M. Josleyn, Krisztina B. Janosko, Jeff Skinner, Roger Keith Reeves, Melanie Cohen, Catherine Jett, Reed Johnson, Joseph E. Blaney, Laura Bollinger et al. · 2013 · PLoS ONE
  99. Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
    Concetta Quintarelli, Simona Sivori, Simona Caruso, Simona Carlomagno, Michela Falco, Iolanda Boffa, Domenico Orlando, Marika Guercio, Zeinab Abbaszadeh, Matilde Sinibaldi et al. · 2019 · Leukemia
  100. The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion
    Nayoung Kim, Aurore Saudemont, Louise M. C. Webb, Montserrat Camps, Thomas Rückle, Emilio Hirsch, Martin Turner, Francesco Colucci · 2007 · Blood